Xi Chu
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacological Effects of Natural Compounds
- Physiology top 5%
- Adenosine and Purinergic Signaling
Papers in
-
- Retinoids in leukemia and cellular processes 6
- Ion channel regulation and function 6
-
- Cardiac electrophysiology and arrhythmias 9
- Co-authors
- Li Chu (34 shared papers)Jianping Zhang (25 shared papers)Xuan Zhang (17 shared papers)Bin Zheng (12 shared papers)Xue Han (18 shared papers)Xue Han (9 shared papers)Yingran Liang (8 shared papers)Yucong Xue (12 shared papers)
- Journals
- International Immunopharmacology (5 papers)Biomedicine & Pharmacotherapy (3 papers)Phytotherapy Research (3 papers)Drug Design Development and Therapy (3 papers)Journal of Ethnopharmacology (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xi Chu
96 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 123
- Pharmacology 237
- Physiology 110
- Complementary and alternative medicine 176
- Biochemistry 76
- Cardiology and Cardiovascular Medicine 237
Countries citing papers authored by Xi Chu
This map shows the geographic impact of Xi Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Chu more than expected).
Fields of papers citing papers by Xi Chu
This network shows the impact of papers produced by Xi Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Chu. The network helps show where Xi Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 105 | |
| 2 | 2019 | 85 | |
| 3 | 2020 | 74 | |
| 4 | 2017 | 74 | |
| 5 | 2009 | 67 | |
| 6 | 2018 | 62 | |
| 7 | 2015 | 62 | |
| 8 | 2020 | 60 | |
| 9 | 2017 | 58 | |
| 10 | 2021 | 57 | |
| 11 | 2017 | 55 | |
| 12 | 2019 | 54 | |
| 13 | 2019 | 48 | |
| 14 | 2017 | 48 | |
| 15 | 2010 | 46 | |
| 16 | 2020 | 46 | |
| 17 | 2016 | 46 | |
| 18 | 2017 | 39 | |
| 19 | 2015 | 39 | |
| 20 | 2014 | 34 |
About Xi Chu
Xi Chu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pharmacology, Oncology and Immunology, having authored 99 papers that have together received 2.1k indexed citations. Recurring topics across this work include Saffron Plant Research Studies (11 papers), Cardiac electrophysiology and arrhythmias (9 papers), Pharmacological Effects of Natural Compounds (8 papers), Retinoids in leukemia and cellular processes (6 papers), Ion channel regulation and function (6 papers), Immune cells in cancer (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Adenosine and Purinergic Signaling (5 papers). The work is most often cited by research in Pharmacology (237 citations), Physiology (110 citations), Complementary and alternative medicine (176 citations), Biochemistry (76 citations) and Cardiology and Cardiovascular Medicine (237 citations). Xi Chu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Li Chu, Jianping Zhang, Xuan Zhang, Bin Zheng, Xue Han, Xue Han, Yingran Liang, Yucong Xue, Jing Shi and Yuanyuan Zhang. Their work appears in journals such as International Immunopharmacology, Biomedicine & Pharmacotherapy, Phytotherapy Research, Drug Design Development and Therapy and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.